
Palonosetron Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.25 mg/5 mL vial
Reference Brands: Aloxi(US) Palonosetron(EU)
Category: Oncology Cancer Care
Palonosetron Injection is available in Injection and strengths such as 0.25 mg/5 mL vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Palonosetron Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Palonosetron Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Palonosetron Injection 0.25 mg/5 mL is a 5-HT3 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting (CINV). It is particularly effective for patients undergoing highly emetogenic chemotherapy regimens. Approved in both the U.S. (under the brand name Aloxi) and the EU, Palonosetron is available as a single-dose 0.25 mg/5 mL vial for IV administration. This drug is essential in oncology B2B distribution, helping oncology centers and hospitals manage the side effects of chemotherapy, ensuring better patient outcomes by reducing nausea and vomiting after treatment.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Daratumumab
Strength:
100 mg/5 mL, 400 mg/20 mL
Form: Injection
Reference Brands: Darzalex (USA/EU)
View DetailsPembrolizumab Inj
Strength:
25 mg/mL
Form: Injection
Reference Brands: Keytruda (USA/EU)
View DetailsLeuprolide
Strength:
3.75 mg, 7.5 mg
Form: Injection
Reference Brands: Lupron (USA), Eligard (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers